Mega Genomics Ltd. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by GUO Meiling, was filed 23 Jan 2025.
Mega Genomics Ltd.: what insiders have been doing
Mega Genomics Ltd. is a Health Care company. Its directors and officers file their transactions with HKEX. The last twelve months, up to 24 October 2026, brought 1 filing signed by 1 insider.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €603k. At €603k, the sale published on 14 September 2026 by Yu Rong is the largest of the period.
Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For context, the typical company on the same exchange (median of 1,315 companies) published 4 filings over the same period, against 1 filing here. Looking back to 2022, when coverage begins, insiders filed 5 purchases and 7 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -19.0%Entry HK$8.89 · Close at T+365 HK$7.20
- -17.3%Entry HK$12.38 · Close at T+365 HK$10.24
- -17.3%Entry HK$12.38 · Close at T+365 HK$10.24
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000,000 shares@ HK$5.50100.0% of flowShareXHKGHKEX:DA20260911E00606
- 14,555,731 sharesShareXHKGHKEX:DA20250124E00363
- 273,970 shares@ HK$7.78100.0% of flowShareXHKGHKEX:DA20250123E00580Canonical exit: 21 Apr 2025 (T+90)
- 800,000 shares@ HK$6.3016.5% of flowShareXHKGHKEX:DA20250123E00578
- 800,000 shares@ HK$6.3016.5% of flowShareXHKGHKEX:DA20241226E00042
- 300,000 shares@ HK$6.306.1% of flowShareXHKGHKEX:DA20241125E00166
- 500,000 shares@ HK$6.3010.0% of flowShareXHKGHKEX:DA20241113E00328
- 800,000 shares@ HK$7.0017.5% of flowShareXHKGHKEX:DA20240729E00418
- 800,000 shares@ HK$7.0017.5% of flowShareXHKGHKEX:DA20240611E00585
- 4,545,333 sharesShareXHKGHKEX:DA20230104E00638
- 1,515,000 sharesShareXHKGHKEX:DA20230104E00636
- 166,666 sharesShareXHKGHKEX:DA20230104E00640
- 166,666 sharesShareXHKGHKEX:DA20230104E00642
- 4,545,000 shares@ HK$9.90100.0% of flowShareXHKGHKEX:DA20230104E00635Canonical exit: 29 Mar 2023 (T+90)
- 500,000 shares@ HK$9.90100.0% of flowShareXHKGHKEX:DA20230104E00639Canonical exit: 29 Mar 2023 (T+90)
- 500,000 shares@ HK$9.90100.0% of flowShareXHKGHKEX:DA20230104E00641Canonical exit: 29 Mar 2023 (T+90)
- 13,636,000 shares@ HK$9.90100.0% of flowShareXHKGHKEX:DA20230104E00637Canonical exit: 29 Mar 2023 (T+90)
- 22,000,000 sharesShareXHKGHKEX:DA20220719E00401
- 44,795,135 sharesShareXHKGHKEX:DA20220719E00397
- 22,000,000 sharesShareXHKGHKEX:DA20220707E00429
- 44,795,135 sharesShareXHKGHKEX:DA20220707E00424
- 3,463,131 sharesShareXHKGHKEX:DA20220707E00457
- 9,975,311 sharesShareXHKGHKEX:DA20220707E00456
23 of 23 declarations
About Mega Genomics Ltd.
Mega Genomics Ltd. is a company specializing in genomics, providing innovative solutions for genetic analysis. It focuses on developing advanced technologies for research and clinical applications.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
